Global Tumour-cell Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tumour-cell Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tumour-cell Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tumour-cell Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Tumour-cell Vaccine Segment by Type

2.2.1 MVax

2.2.2 OncoVAX

2.2.3 BiovaxID

2.2.4 Others

2.3 Tumour-cell Vaccine Sales by Type

2.3.1 Global Tumour-cell Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Tumour-cell Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tumour-cell Vaccine Sale Price by Type (2017-2022)

2.4 Tumour-cell Vaccine Segment by Application

2.4.1 Pediatrics

2.4.2 Adults

2.5 Tumour-cell Vaccine Sales by Application

2.5.1 Global Tumour-cell Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Tumour-cell Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tumour-cell Vaccine Sale Price by Application (2017-2022)

3 Global Tumour-cell Vaccine by Company

3.1 Global Tumour-cell Vaccine Breakdown Data by Company

3.1.1 Global Tumour-cell Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Tumour-cell Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Tumour-cell Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Tumour-cell Vaccine Revenue by Company (2020-2022)

3.2.2 Global Tumour-cell Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Tumour-cell Vaccine Sale Price by Company

3.4 Key Manufacturers Tumour-cell Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tumour-cell Vaccine Product Location Distribution

3.4.2 Players Tumour-cell Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tumour-cell Vaccine by Geographic Region

4.1 World Historic Tumour-cell Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Tumour-cell Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tumour-cell Vaccine Annual Revenue by Geographic Region

4.2 World Historic Tumour-cell Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Tumour-cell Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tumour-cell Vaccine Annual Revenue by Country/Region

4.3 Americas Tumour-cell Vaccine Sales Growth

4.4 APAC Tumour-cell Vaccine Sales Growth

4.5 Europe Tumour-cell Vaccine Sales Growth

4.6 Middle East & Africa Tumour-cell Vaccine Sales Growth

5 Americas

5.1 Americas Tumour-cell Vaccine Sales by Country

5.1.1 Americas Tumour-cell Vaccine Sales by Country (2017-2022)

5.1.2 Americas Tumour-cell Vaccine Revenue by Country (2017-2022)

5.2 Americas Tumour-cell Vaccine Sales by Type

5.3 Americas Tumour-cell Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tumour-cell Vaccine Sales by Region

6.1.1 APAC Tumour-cell Vaccine Sales by Region (2017-2022)

6.1.2 APAC Tumour-cell Vaccine Revenue by Region (2017-2022)

6.2 APAC Tumour-cell Vaccine Sales by Type

6.3 APAC Tumour-cell Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tumour-cell Vaccine by Country

7.1.1 Europe Tumour-cell Vaccine Sales by Country (2017-2022)

7.1.2 Europe Tumour-cell Vaccine Revenue by Country (2017-2022)

7.2 Europe Tumour-cell Vaccine Sales by Type

7.3 Europe Tumour-cell Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tumour-cell Vaccine by Country

8.1.1 Middle East & Africa Tumour-cell Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tumour-cell Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Tumour-cell Vaccine Sales by Type

8.3 Middle East & Africa Tumour-cell Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tumour-cell Vaccine

10.3 Manufacturing Process Analysis of Tumour-cell Vaccine

10.4 Industry Chain Structure of Tumour-cell Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tumour-cell Vaccine Distributors

11.3 Tumour-cell Vaccine Customer

12 World Forecast Review for Tumour-cell Vaccine by Geographic Region

12.1 Global Tumour-cell Vaccine Market Size Forecast by Region

12.1.1 Global Tumour-cell Vaccine Forecast by Region (2023-2028)

12.1.2 Global Tumour-cell Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tumour-cell Vaccine Forecast by Type

12.7 Global Tumour-cell Vaccine Forecast by Application

13 Key Players Analysis

13.1 AVAX Technologies

13.1.1 AVAX Technologies Company Information

13.1.2 AVAX Technologies Tumour-cell Vaccine Product Offered

13.1.3 AVAX Technologies Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AVAX Technologies Main Business Overview

13.1.5 AVAX Technologies Latest Developments

13.2 Vaccinogen

13.2.1 Vaccinogen Company Information

13.2.2 Vaccinogen Tumour-cell Vaccine Product Offered

13.2.3 Vaccinogen Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Vaccinogen Main Business Overview

13.2.5 Vaccinogen Latest Developments

13.3 Biovest

13.3.1 Biovest Company Information

13.3.2 Biovest Tumour-cell Vaccine Product Offered

13.3.3 Biovest Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biovest Main Business Overview

13.3.5 Biovest Latest Developments

13.4 Aduro BioTech

13.4.1 Aduro BioTech Company Information

13.4.2 Aduro BioTech Tumour-cell Vaccine Product Offered

13.4.3 Aduro BioTech Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Aduro BioTech Main Business Overview

13.4.5 Aduro BioTech Latest Developments

13.5 Regeneus

13.5.1 Regeneus Company Information

13.5.2 Regeneus Tumour-cell Vaccine Product Offered

13.5.3 Regeneus Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Regeneus Main Business Overview

13.5.5 Regeneus Latest Developments

14 Research Findings and Conclusion

Table 1. Tumour-cell Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tumour-cell Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of MVax

Table 4. Major Players of OncoVAX

Table 5. Major Players of BiovaxID

Table 6. Major Players of Others

Table 7. Global Tumour-cell Vaccine Sales by Type (2017-2022) & (K Units)

Table 8. Global Tumour-cell Vaccine Sales Market Share by Type (2017-2022)

Table 9. Global Tumour-cell Vaccine Revenue by Type (2017-2022) & ($ million)

Table 10. Global Tumour-cell Vaccine Revenue Market Share by Type (2017-2022)

Table 11. Global Tumour-cell Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Tumour-cell Vaccine Sales by Application (2017-2022) & (K Units)

Table 13. Global Tumour-cell Vaccine Sales Market Share by Application (2017-2022)

Table 14. Global Tumour-cell Vaccine Revenue by Application (2017-2022)

Table 15. Global Tumour-cell Vaccine Revenue Market Share by Application (2017-2022)

Table 16. Global Tumour-cell Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Tumour-cell Vaccine Sales by Company (2020-2022) & (K Units)

Table 18. Global Tumour-cell Vaccine Sales Market Share by Company (2020-2022)

Table 19. Global Tumour-cell Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Tumour-cell Vaccine Revenue Market Share by Company (2020-2022)

Table 21. Global Tumour-cell Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Tumour-cell Vaccine Producing Area Distribution and Sales Area

Table 23. Players Tumour-cell Vaccine Products Offered

Table 24. Tumour-cell Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Tumour-cell Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Tumour-cell Vaccine Sales Market Share Geographic Region (2017-2022)

Table 29. Global Tumour-cell Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Tumour-cell Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Tumour-cell Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Tumour-cell Vaccine Sales Market Share by Country/Region (2017-2022)

Table 33. Global Tumour-cell Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Tumour-cell Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Tumour-cell Vaccine Sales by Country (2017-2022) & (K Units)

Table 36. Americas Tumour-cell Vaccine Sales Market Share by Country (2017-2022)

Table 37. Americas Tumour-cell Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Tumour-cell Vaccine Revenue Market Share by Country (2017-2022)

Table 39. Americas Tumour-cell Vaccine Sales by Type (2017-2022) & (K Units)

Table 40. Americas Tumour-cell Vaccine Sales Market Share by Type (2017-2022)

Table 41. Americas Tumour-cell Vaccine Sales by Application (2017-2022) & (K Units)

Table 42. Americas Tumour-cell Vaccine Sales Market Share by Application (2017-2022)

Table 43. APAC Tumour-cell Vaccine Sales by Region (2017-2022) & (K Units)

Table 44. APAC Tumour-cell Vaccine Sales Market Share by Region (2017-2022)

Table 45. APAC Tumour-cell Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Tumour-cell Vaccine Revenue Market Share by Region (2017-2022)

Table 47. APAC Tumour-cell Vaccine Sales by Type (2017-2022) & (K Units)

Table 48. APAC Tumour-cell Vaccine Sales Market Share by Type (2017-2022)

Table 49. APAC Tumour-cell Vaccine Sales by Application (2017-2022) & (K Units)

Table 50. APAC Tumour-cell Vaccine Sales Market Share by Application (2017-2022)

Table 51. Europe Tumour-cell Vaccine Sales by Country (2017-2022) & (K Units)

Table 52. Europe Tumour-cell Vaccine Sales Market Share by Country (2017-2022)

Table 53. Europe Tumour-cell Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Tumour-cell Vaccine Revenue Market Share by Country (2017-2022)

Table 55. Europe Tumour-cell Vaccine Sales by Type (2017-2022) & (K Units)

Table 56. Europe Tumour-cell Vaccine Sales Market Share by Type (2017-2022)

Table 57. Europe Tumour-cell Vaccine Sales by Application (2017-2022) & (K Units)

Table 58. Europe Tumour-cell Vaccine Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Tumour-cell Vaccine Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Tumour-cell Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Tumour-cell Vaccine Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Tumour-cell Vaccine Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Tumour-cell Vaccine Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Tumour-cell Vaccine

Table 68. Key Market Challenges & Risks of Tumour-cell Vaccine

Table 69. Key Industry Trends of Tumour-cell Vaccine

Table 70. Tumour-cell Vaccine Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Tumour-cell Vaccine Distributors List

Table 73. Tumour-cell Vaccine Customer List

Table 74. Global Tumour-cell Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Tumour-cell Vaccine Sales Market Forecast by Region

Table 76. Global Tumour-cell Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Tumour-cell Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Tumour-cell Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Tumour-cell Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Tumour-cell Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Tumour-cell Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Tumour-cell Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Tumour-cell Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Tumour-cell Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Tumour-cell Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Tumour-cell Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Tumour-cell Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Tumour-cell Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Tumour-cell Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Tumour-cell Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Tumour-cell Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Tumour-cell Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Tumour-cell Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 94. AVAX Technologies Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 95. AVAX Technologies Tumour-cell Vaccine Product Offered

Table 96. AVAX Technologies Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. AVAX Technologies Main Business

Table 98. AVAX Technologies Latest Developments

Table 99. Vaccinogen Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 100. Vaccinogen Tumour-cell Vaccine Product Offered

Table 101. Vaccinogen Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Vaccinogen Main Business

Table 103. Vaccinogen Latest Developments

Table 104. Biovest Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 105. Biovest Tumour-cell Vaccine Product Offered

Table 106. Biovest Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Biovest Main Business

Table 108. Biovest Latest Developments

Table 109. Aduro BioTech Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 110. Aduro BioTech Tumour-cell Vaccine Product Offered

Table 111. Aduro BioTech Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Aduro BioTech Main Business

Table 113. Aduro BioTech Latest Developments

Table 114. Regeneus Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 115. Regeneus Tumour-cell Vaccine Product Offered

Table 116. Regeneus Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Regeneus Main Business

Table 118. Regeneus Latest Developments

List of Figures

Figure 1. Picture of Tumour-cell Vaccine

Figure 2. Tumour-cell Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tumour-cell Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Tumour-cell Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tumour-cell Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of MVax

Figure 10. Product Picture of OncoVAX

Figure 11. Product Picture of BiovaxID

Figure 12. Product Picture of Others

Figure 13. Global Tumour-cell Vaccine Sales Market Share by Type in 2021

Figure 14. Global Tumour-cell Vaccine Revenue Market Share by Type (2017-2022)

Figure 15. Tumour-cell Vaccine Consumed in Pediatrics

Figure 16. Global Tumour-cell Vaccine Market: Pediatrics (2017-2022) & (K Units)

Figure 17. Tumour-cell Vaccine Consumed in Adults

Figure 18. Global Tumour-cell Vaccine Market: Adults (2017-2022) & (K Units)

Figure 19. Global Tumour-cell Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Tumour-cell Vaccine Revenue Market Share by Application in 2021

Figure 21. Tumour-cell Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Tumour-cell Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Tumour-cell Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Tumour-cell Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Tumour-cell Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Tumour-cell Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Tumour-cell Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Tumour-cell Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Tumour-cell Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Tumour-cell Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Tumour-cell Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Tumour-cell Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Tumour-cell Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Tumour-cell Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Tumour-cell Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Tumour-cell Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Tumour-cell Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Tumour-cell Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Tumour-cell Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Tumour-cell Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Tumour-cell Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Tumour-cell Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Tumour-cell Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Tumour-cell Vaccine

Figure 65. Industry Chain Structure of Tumour-cell Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles